CVS HEALTH Corp·4

Feb 14, 5:13 PM ET

Clark James David 4

4 · CVS HEALTH Corp · Filed Feb 14, 2024

Insider Transaction Report

Form 4
Period: 2024-02-12
Clark James David
SVP, Cont & Chief Acct Officer
Transactions
  • Award

    Common Stock

    2024-02-12+2,4527,150 total
Holdings
  • Common Stock (Restricted)

    8,760
  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03Common Stock (9,050 underlying)
    9,050
  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01Common Stock (7,513 underlying)
    7,513
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (24,240 underlying)
    24,240
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (17,157 underlying)
    17,157
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (12,094 underlying)
    12,094
  • Stock Option

    Exercise: $101.09From: 2023-04-01Exp: 2032-04-01Common Stock (6,756 underlying)
    6,756
  • Stock Option

    Exercise: $74.31From: 2024-04-01Exp: 2033-04-01Common Stock (9,649 underlying)
    9,649
Footnotes (9)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
  • [F2]Options became exercisable in four equal annual installments beginning on 4/3/2018.
  • [F3]Options became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F4]Options became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F5]The number of shares subject to the option were calculated using a 30-day average price.
  • [F6]Options became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F7]Option became exercisable in four equal annual installments, commencing 4/1/2022.
  • [F8]Option became exercisable in four equal installments, commencing 4/1/2023.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT